Letter to the Director

DOI: 10.1016/j.redare.2024.04.002

QT-prolongation in patients with severe COVID-19 is multicausal and not limited to anti-SARS-CoV-2 drugs

La prolongación del intervalo QT en los pacientes con COVID-19 severa es multicausal y no se limita a los fármacos anti-SARS-CoV-2

Visitas

88

Descargar PDF

J. Finsterera,

Autor para correspondencia

fifigs1@yahoo.de

Corresponding author.

, C. Stöllbergerb

a Neurology & Neurophysiology Center, Vienna, Austria

b 2nd Medical Department, Klinik Landstrasse, Vienna, Austria